US Stocks
/
Dermata Therapeutics, Inc. Share Price

Dermata Therapeutics, Inc. Share Price

NASDAQ: DRMA | Micro Cap
$1.04
-$0.01 (-0.95%) Last updated on 10 Oct, 2026 | 00:49 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Dermata Therapeutics, Inc. Stock Performance

Open
$1.04
Prev. Close
$1.05
Circuit Range
N/A
Day Range
$1.04 - $1.04
Year Range
$1.04 - $4.74
Volume
100
Average Traded
$1.04

Dermata Therapeutics, Inc. Share Price Today

As of 10 October 2026, Dermata Therapeutics, Inc.'s share price is $1.04. The stock opened at $1.04, compared to its previous close of $1.05. During today's trading session, Dermata Therapeutics, Inc.'s share price traded between $1.04 and $1.04, with an average price of $1.04. Over the past 52 weeks, the stock has recorded a high of $4.74 and a low of $1.04. In terms of performance, Dermata Therapeutics, Inc.'s share price has declined by 23.53% over the last six months and is down 69.50% on a year-on-year basis.

Dermata Therapeutics, Inc. Share Price Chart

$1.04$1.04
L
Show Current Price
H

Dermata Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$963239.68
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.69
Revenue (TTM)
$0.00
Return On Equity (TTM)
-239.95%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-75.74%

Dermata Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.69-$1.86-$1.85-$2.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-10.06%0.54%-60.54%

Dermata Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.61-$7.79-$12.29-$7.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A18.94%-57.77%38.49%

About Dermata Therapeutics, Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Dermata Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.14
$1.04
-6.31%
Sep 2026
$1.26
$1.11
-28.85%
Aug 2026
$1.05
$1.56
+31.09%
Jul 2026
$1.33
$1.19
-7.03%
Jun 2026
$1.32
$1.28
-1.54%
May 2026
$1.36
$1.30
-4.41%
Apr 2026
$1.23
$1.36
+7.09%
Mar 2026
$1.19
$1.27
+4.96%
Feb 2026
$2.18
$1.21
-46.22%
Jan 2026
$2.21
$2.25
-4.86%
Dec 2025
$2.91
$2.37
-22.46%
Nov 2025
$3.33
$3.05
-10.56%

DRMA Share Price FAQs

What is Dermata Therapeutics, Inc. share price today?

chevron-up
Dermata Therapeutics, Inc. share price today is $1.04 as on October 10, 2026 at 12:49 am IST.

What is the 52 week high and 52 week low of Dermata Therapeutics, Inc. stock?

chevron-up
The 52 week high of Dermata Therapeutics, Inc. stock is $4.74, while the 52 week low is $1.04 as of 10 Oct '26.

What is DRMA's market capitalisation today?

chevron-up
DRMA market capitalisation is $963239.68 as of October 10, 2026, at 4:41 am IST.

What is DRMA's net income for the last quarter?

chevron-up
DRMA's net income for the last quarter is -2.97B USD.

What is the 5 year returns of DRMA?

chevron-up
The 5 year returns of DRMA is -99.91% as on 10 Oct '26.

What is the high & low stock price of DRMA today?

chevron-up
DRMA stock price hit a high of $1.04 and low of $1.04 as of 10 Oct '26.

Can I buy DRMA shares in India?

chevron-up
Yes. You can buy DRMA in India by opening an international trading account.